StockWatch
·
Pharmaceuticals
Board Meeting27 Oct 2026, 11:12 am

Wockhardt Board Meeting on Nov 2, 2026 for Q2 FY27 Results

AI Summary

Wockhardt Ltd has announced that its Board of Directors will convene on November 2, 2026, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company has informed that the trading window for its shares will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results.

Key Highlights

  • Board meeting scheduled for November 2, 2026.
  • To approve un-audited financial results for Q2 FY27.
  • Trading window closure extended until post-results announcement.
  • Focus on financial performance for the quarter and half-year.